Assembled small organic molecules for photodynamic therapy and photothermal therapy

Lixin Sun1, Jian Wang1, Baochan Yang1

  • 1Beijing Key Laboratory for Science and Application of Functional Molecular and Crystalline Materials, Department of Chemistry, University of Science and Technology Beijing Beijing 100083 China twang@ustb.edu.cn jianzhuang@ustb.edu.cn.

RSC Advances
|April 15, 2022
PubMed

Insights

Cancer remains a major health challenge. This review explores supramolecular assembly of organic molecules for advanced photodynamic therapy (PDT) and photothermal therapy (PTT) cancer treatments.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Cancer is a leading global cause of mortality, necessitating innovative therapeutic strategies.
  • Photodynamic therapy (PDT) and photothermal therapy (PTT) offer promising, low-side-effect anti-tumour approaches.
  • Natural supramolecular architectures inspire the development of novel therapeutic agents.

Purpose of the Study:

  • To review recent advancements in PDT and PTT utilizing small organic molecule assemblies.
  • To highlight the potential of supramolecular chemistry in developing targeted cancer therapies.

Main Methods:

  • Focuses on the hierarchical supramolecular assembly of small organic molecules.
  • Discusses the application of these assemblies as photosensitizers for PDT and photothermal agents for PTT.

Main Results:

  • Supramolecular assemblies of organic molecules show significant potential for PDT and PTT.
  • These assemblies can be designed to act as effective photosensitizers and photothermal agents.

Conclusions:

  • The assembly of small organic molecules represents a powerful strategy for developing advanced PDT and PTT agents.
  • This approach holds promise for improving cancer treatment efficacy and reducing side effects.

Related Concept Videos